Monday, September 14, 2020

Tracking President Trump’s Record on Health Care

 

Not rendering correctly? View this email as a web page here.
Not a subscriber? Sign up

KFF

Just Released

From the Federal Response to COVID-19 to Ongoing Efforts to Repeal the ACA and Proposals for Lowering Drug Prices, President Trump Has an Extensive Record on Health Care

Since taking office in 2017, President Trump has laid down an extensive record on health care, including his response to the COVID-19 pandemic, his early and ongoing efforts to repeal and replace the Affordable Care Act (ACA), his annual budget proposals to curb spending on Medicare and Medicaid, his executive orders and other proposals to lower prescription drug prices, and his initiative on hospital price transparency.

President Trump’s record on health care provides a window into his policy priorities in an area that represents one-fifth of the U.S. economy and affects the lives of every American. A new issue brief from KFF describes the Trump Administration’s record on health care, including major proposals and actions relating to the COVID-19 pandemic, the ACA and private insurance markets, Medicaid, Medicare, prescription drugs and other health costs, sexual and reproductive health, mental health and substance use, immigration and health, long-term care, HIV/AIDS policy, and LGBTQ health.

The new resource is part of KFF’s ongoing efforts to provide timely and useful information about health policy issues relevant to the 2020 elections, including policy analysis, polling, and journalism. Find more on our Election 2020 resource page, including a side-by-side comparison of President Trump’s record and Democratic presidential nominee Joe Biden’s positions on key health issues.

Read the Issue Brief

Filling the need for trusted information on national health issues, KFF (Kaiser Family Foundation) is a nonprofit organization based in San Francisco, California.

Contact:

Chris Lee | (202) 654-1403 | clee@kff.org

kff.org | khn.org

Connect with us: email-icon facebook-icon twitter-icon instagram-icon

Share this email   

   

No comments:

Post a Comment